+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiac Resynchronization"

From
UAE Pacemaker Market, By Region, By Competition Forecast & Opportunities, 2018-2028F - Product Thumbnail Image

UAE Pacemaker Market, By Region, By Competition Forecast & Opportunities, 2018-2028F

  • Report
  • November 2023
  • 83 Pages
  • United Arab Emirates United Arab Emirates
From
From
From
From
From
From
Global Cardiac Rhythm Management Devices, 2022 - Product Thumbnail Image

Global Cardiac Rhythm Management Devices, 2022

  • Report
  • January 2023
  • 87 Pages
  • Global
From
From
Pacemakers-Pipeline Insight and Competitive Landscape, 2022 - Product Thumbnail Image

Pacemakers-Pipeline Insight and Competitive Landscape, 2022

  • Drug Pipelines
  • July 2022
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Cardiac Resynchronization (CRT) is a type of cardiovascular device used to treat heart failure. It is a therapy that uses electrical stimulation to synchronize the contractions of the left and right ventricles of the heart. This helps to improve the heart's pumping efficiency and reduce symptoms of heart failure. CRT is typically used in combination with other treatments such as medications, lifestyle changes, and implantable cardioverter-defibrillators (ICDs). CRT devices are typically implanted in the chest and consist of a pulse generator, leads, and electrodes. The pulse generator sends electrical signals to the heart through the leads and electrodes, which are connected to the left and right ventricles. The electrical signals help to coordinate the contractions of the ventricles, improving the heart's pumping efficiency. CRT is a rapidly growing market, with a wide range of products available from various manufacturers. Companies in the market include Medtronic, Abbott, Boston Scientific, Biotronik, and St. Jude Medical. Show Less Read more